Vanguard Group’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$632M Sell
10,708,893
-200,189
-2% -$11.8M 0.01% 901
2025
Q1
$799M Buy
10,909,082
+45,248
+0.4% +$3.31M 0.01% 737
2024
Q4
$899M Buy
10,863,834
+240,218
+2% +$19.9M 0.02% 714
2024
Q3
$760M Sell
10,623,616
-50,330
-0.5% -$3.6M 0.01% 797
2024
Q2
$731M Sell
10,673,946
-280,735
-3% -$19.2M 0.01% 777
2024
Q1
$588M Sell
10,954,681
-323,041
-3% -$17.3M 0.01% 910
2023
Q4
$601M Buy
11,277,722
+32,220
+0.3% +$1.72M 0.01% 864
2023
Q3
$558M Buy
11,245,502
+3,732,959
+50% +$185M 0.01% 836
2023
Q2
$447M Sell
7,512,543
-32,207
-0.4% -$1.92M 0.01% 991
2023
Q1
$427M Buy
7,544,750
+212,638
+3% +$12M 0.01% 998
2022
Q4
$545M Buy
7,332,112
+139,413
+2% +$10.4M 0.01% 830
2022
Q3
$428M Sell
7,192,699
-266,429
-4% -$15.9M 0.01% 918
2022
Q2
$419M Buy
7,459,128
+53,619
+0.7% +$3.01M 0.01% 968
2022
Q1
$546M Sell
7,405,509
-104,398
-1% -$7.7M 0.01% 905
2021
Q4
$542M Buy
7,509,907
+196,405
+3% +$14.2M 0.01% 947
2021
Q3
$560M Buy
7,313,502
+59,824
+0.8% +$4.58M 0.01% 914
2021
Q2
$562M Buy
7,253,678
+155,870
+2% +$12.1M 0.01% 920
2021
Q1
$438M Buy
7,097,808
+231,555
+3% +$14.3M 0.01% 1037
2020
Q4
$448M Buy
6,866,253
+192,154
+3% +$12.5M 0.01% 936
2020
Q3
$331M Sell
6,674,099
-318,315
-5% -$15.8M 0.01% 970
2020
Q2
$334M Sell
6,992,414
-476,078
-6% -$22.7M 0.01% 960
2020
Q1
$318M Buy
7,468,492
+180,265
+2% +$7.67M 0.01% 871
2019
Q4
$429M Buy
7,288,227
+40,545
+0.6% +$2.39M 0.01% 907
2019
Q3
$371M Buy
7,247,682
+66,627
+0.9% +$3.41M 0.01% 958
2019
Q2
$304M Buy
7,181,055
+31,142
+0.4% +$1.32M 0.01% 1102
2019
Q1
$353M Buy
7,149,913
+123,239
+2% +$6.09M 0.01% 976
2018
Q4
$304M Buy
7,026,674
+291,180
+4% +$12.6M 0.01% 971
2018
Q3
$382M Buy
6,735,494
+219,780
+3% +$12.5M 0.01% 951
2018
Q2
$329M Buy
6,515,714
+479,584
+8% +$24.2M 0.01% 1020
2018
Q1
$301M Buy
6,036,130
+93,403
+2% +$4.65M 0.01% 1028
2017
Q4
$244M Buy
5,942,727
+85,057
+1% +$3.5M 0.01% 1171
2017
Q3
$174M Buy
5,857,670
+145,627
+3% +$4.33M 0.01% 1370
2017
Q2
$189M Buy
5,712,043
+76,345
+1% +$2.53M 0.01% 1263
2017
Q1
$167M Buy
5,635,698
+240,257
+4% +$7.12M 0.01% 1342
2016
Q4
$134M Buy
5,395,441
+260,106
+5% +$6.45M 0.01% 1449
2016
Q3
$116M Buy
5,135,335
+142,829
+3% +$3.22M 0.01% 1470
2016
Q2
$119M Buy
4,992,506
+127,738
+3% +$3.04M 0.01% 1400
2016
Q1
$116M Buy
4,864,768
+105,518
+2% +$2.51M 0.01% 1392
2015
Q4
$132M Buy
4,759,250
+139,123
+3% +$3.87M 0.01% 1267
2015
Q3
$95.5M Buy
4,620,127
+89,828
+2% +$1.86M 0.01% 1462
2015
Q2
$116M Buy
4,530,299
+182,754
+4% +$4.69M 0.01% 1420
2015
Q1
$110M Buy
4,347,545
+55,674
+1% +$1.41M 0.01% 1435
2014
Q4
$102M Buy
4,291,871
+78,858
+2% +$1.87M 0.01% 1400
2014
Q3
$82.9M Buy
4,213,013
+285,970
+7% +$5.63M 0.01% 1490
2014
Q2
$93.9M Buy
3,927,043
+232,808
+6% +$5.57M 0.01% 1437
2014
Q1
$98.2M Buy
3,694,235
+195,149
+6% +$5.19M 0.01% 1356
2013
Q4
$70.6M Buy
3,499,086
+339,741
+11% +$6.86M 0.01% 1553
2013
Q3
$55.2M Buy
3,159,345
+587,827
+23% +$10.3M 0.01% 1661
2013
Q2
$43.4M Buy
+2,571,518
New +$43.4M ﹤0.01% 1722